Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37573
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rolnik D.L. | en |
dc.contributor.author | Reddy M. | en |
dc.contributor.author | da Silva Costa F. | en |
dc.contributor.author | Springhall E.A. | en |
dc.date.accessioned | 2021-05-14T12:47:19Z | en |
dc.date.available | 2021-05-14T12:47:19Z | en |
dc.date.copyright | 2018 | en |
dc.date.created | 20181127 | en |
dc.date.issued | 2018-11-27 | en |
dc.identifier.citation | Australasian Journal of Ultrasound in Medicine. 21 (4) (pp 191-197), 2018. Date of Publication: November 2018. | en |
dc.identifier.issn | 1836-6864 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/37573 | en |
dc.description.abstract | Pre-eclampsia is a common condition that affects 2-5% of pregnancies and is associated with significant maternal and perinatal morbidity, and cost to the healthcare system. In those at high risk for pre-eclampsia, interventions such as aspirin intake have been shown to reduce prevalence of disease. However, to implement these interventions, it is essential that high-risk women be identified early in pregnancy. A combined first trimester screening model for pre-eclampsia that includes maternal history, mean arterial pressure, uterine artery Doppler and PlGF has been shown to be the most effective at identifying the population at greatest risk of pre-eclampsia. This article will explore the most appropriate methods of measuring the components of first trimester screening and discuss the use of aspirin for prevention of pre-eclampsia in pregnancy.Copyright © 2018 Australasian Society for Ultrasound in Medicine | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | John Wiley and Sons Inc. (E-mail: cs-journals@wiley.com) | en |
dc.title | How to perform first trimester combined screening for pre-eclampsia. | en |
dc.type | Article | en |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/ajum.12111 | en |
dc.publisher.place | United States | en |
dc.identifier.orcid | Reddy, Maya; ORCID: http://orcid.org/0000-0002-4251-7193 Rolnik, Daniel Lorber; ORCID: http://orcid.org/0000-0002-2263-3592 | en |
dc.identifier.source | 623909669 | en |
dc.identifier.institution | (Reddy, Springhall, Rolnik, da Silva Costa) Perinatal Services, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, Australia (Reddy, da Silva Costa) Department of Obstetrics and Gynaecology, Monash University, 246 Clayton Road, Clayton, VIC, Australia (da Silva Costa) Monash Ultrasound for Women, Melbourne, VIC, Australia | en |
dc.description.address | D.L. Rolnik, Perinatal Services, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, Australia. E-mail: daniel.rolnik@nhs.net | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2018 Elsevier B.V., All rights reserved. | en |
dc.subect.keywords | first trimester screening maternal history mean arterial pressure placental growth factor pre-eclampsia pregnancy associated plasma protein A uterine artery Doppler | en |
dc.identifier.authoremail | Rolnik D.L.; daniel.rolnik@nhs.net | en |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
crisitem.author.dept | Obstetrics and Gynaecology (Monash Women's) | - |
crisitem.author.dept | Obstetrics and Gynaecology (Monash Women's) | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.